Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
922 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypoglycemic Agents"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
2 Recruiting White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis
Conditions: Chronic Periodontitis;   Diabetes Mellitus, Type 2
Interventions: Procedure: ADT+FD;   Procedure: FD
3 Recruiting Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
Conditions: Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion
Interventions: Procedure: biliopancreatic diversion;   Drug: antidiabetics
4 Recruiting IMS® DIAREG Diabetes Registry
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: antidiabetic treatment (ATC A10B)
5 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
6 Recruiting Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Condition: Hypoglycemia
Intervention: Procedure: euglycemic and hypoglycemic clamp
7 Recruiting A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2963016;   Drug: LANTUS®;   Drug: Oral Antihyperglycemic Medication
8 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
9 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
10 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
11 Recruiting Effects of Glucagon Administration on Energy Expenditure
Conditions: Hyperglucagonemia;   Obesity
Interventions: Drug: Glucagon;   Drug: Octreotide;   Behavioral: Placebo;   Drug: Insulin
12 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
13 Recruiting Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
14 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Pioglitazone;   Other: Placebo
15 Recruiting Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention:
16 Recruiting Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Condition: Diabetes Mellitus
Interventions: Other: Experimental Group instructions for glucose management via App;   Other: Placebo Comparator general instructions
17 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
18 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
19 Recruiting Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine U300 HOE901;   Drug: Insulin glargine HOE901
20 Recruiting A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years